Concepedia

Joshua Basler

JB

Statistics

Publications

2

Citations

54

H-Index

2

Active since

2006

Affiliations

Seagen (United States)(Current)

Joshua Basler is an author at Seagen (United States) specializing in combinatorial mutagenesis, therapeutic antibody development, and antibody-directed enzyme prodrug therapy.

Publications per year

2006–2006

2

Publications

2

Characterization of a CC49-Based Single-Chain Fragment−β-Lactamase Fusion Protein for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)

Ralph Alderson, Brian E. Toki, Martin Roberge et al. · Bioconjugate Chemistry · 2006 · 39 citations

, , +17

Construction and optimization of a CC49-Based scFv-β-lactamase fusion protein for ADEPT

Martin Roberge, Melodie Estabrook, Joshua Basler et al. · Protein Engineering Design and Selection · 2006 · 15 citations · Full text

, , +17

1–2 of 2